This was a retrospective study using national administrative data from the MarketScan database.
To investigate the complication rates, quality outcomes
, and costs in a nationwide cohort of patients with movement disorders (MD) who undergo spinal deformity surgery
Summary of Background Data.
Patients with MD often present with spinal deformities, but their tolerance for surgical intervention is unknown.
The MarketScan administrative claims database was queried to identify adult patients with MD who underwent spinal deformity surgery
. A propensity-score match was conducted to create two uniform cohorts and mitigate interpopulation confounders. Perioperative complication rates, 90-day postoperative outcomes
, and total costs were compared between patients with MD and controls.
A total of 316 patients with MD (1.7%) were identified from the 18,970 undergoing spinal deformity surgery
. The complication rate for MD patients was 44.6% and for the controls 35.6% (P
= 0.009). The two most common perioperative complications were more likely to occur in MD patients, acute-posthemorrhagic anemia (26.9% vs.
< 0.05) and deficiency anemia (15.5% vs.
< 0.05). At 90 days, MD patients were more likely to be readmitted (17.4% vs.
< 0.05) and have a higher total cost ($94,672 vs.
< 0.05). After propensity-score match, the overall complication rate remained higher in the MD group (44.6% vs.
< 0.05). 90-day readmissions and costs also remained significantly higher in the MD cohort. Multivariate modeling revealed MD was an independent predictor of postoperative complication and inpatient readmission. Subgroup analysis revealed that Parkinson disease
was an independent predictor of inpatient readmission, reoperation, and increased length of stay.
Patients with MD who undergo spinal deformity surgery
may be at risk of higher rate of perioperative complications and 90-day readmissions compared with patients without these disorders.
Level of Evidence: 3